Quality assessment of psychopharmacological treatment in mental health hospitals in Turkey;Türkiye'deki ruh hastaliklari hastanelerindeki psikofarmakolojik tedavilerin kalite yönünden deǧerlendirilmesi

Klinik Psikofarmakoloji Bulteni

Volumn 14, Issue 2, 2004, Pages 68-78

  Ensari, Hülya ^a   Ceylan, M Emin ^b   Kilinç, Emine ^b   Kenar, Jülide ^b  

^a Bolu Devlet Hastanesi   (Turkey)

^b Psikiyatri Birimi ^*  (Turkey)

Author keywords

Mental health hospitals; Psychopharmacologic treatments; Quality

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; LITHIUM; NEUROLEPTIC AGENT;

ARTICLE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MENTAL HOSPITAL; POLYPHARMACY; PSYCHOPHARMACOLOGY; QUALITY CONTROL; TURKEY (REPUBLIC);

EID: 3242666363     PISSN: 10177833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Manual of Psychiatric Quality Assurance: Mattson MR, Wilson GF, American Psychiatric Association Committe on Quality Assurance, Washington DC: Am Psychiatric Press, 1991
2. Fauman MA. Quality assurance monitoring in psychiatry. Am J Psychiatry 1989;146:1121-1130
3. Brook RH, Appel FA. Quality-of- care assesment: choosing a method for peer review N Engl J Med 1973;288:1323-1329
4. Schaub RT. Quality assurance in psychiatric care. Pharmacopsychiatry 1994;27(suppl 1):46-50
5. Kessner DM. Quality assessment and assurance: early signs of cognitive dissonance. N Eng J Med 1978;298:381-386
6. American Psychiatric Press Review of Psychiatry, Section-V: Hospital Psychiatry, Volume 11. Edited by Tasman A, Riba MB. Washington, DC: Am Psychiatric Press, 1992
7. Kessner DM, Kalk CE, Singer J. Assessing health quality-the case for tracers. N Engl J Med 1973;288:189-194
8. Sateia MJ, Gustafson DH, Jonhson SW. Quality assurance for psychiatric emergencies. An analysis of assessment and feedback methodologies. Psychiatr Clin North Am 1990;13:35-48
9. Donabedian A. The quality of care. How can it be assessed?JAMA 1988;260:1743-1748
10. Liptzin B. Quality assurance and psychiatric practice: a review. Am J Psychiatry 1974;131:1374-1377
11. Eppel AB, Fuyarchuk c, Phelps D, Phelan AT. A comprehensive and practical quality assurance program for community mental health services. Can J Psychiaty 1991;36:102-106
12. Schyve PM, Prevost JA: From quality assurance to quality improvement, Psychiatr Clin North Am 1990;13:61-71
13. Dorsey R, Ayd FJ Jr, Cole J, Klein D, Simpson G, Tupin J, DiMascia A. Psychopharmacolagic screening criteria development project. JAMA 1979;241:1021-1031
14. Türkiye Istatistik Yilliǧi, T.C. Başbakanlik Devlet Istatistik Enstitüsü, 1998
15. Türkiye'de ruh saǧliǧi alaninda eǧitim ve hizmet veren kurumlarin deǧerlendirmesi. Psikiyatri, Psikoloji ve Psikofarmakoloji Dergisi 1993;1 (ek 1):10-57
16. Diamond H, Tislow R, Synder T Jr, Rickles K. Peer review of prescribing patterns in a CMHC. Am J Psychiatry 1976;133:697-699
17. Michel K, Kolakowska T. A survey of prescribing psychotropic drugs in two psychiatric hospitals. Br J Psychiatry 1981;138:217-221
18. Gelder M, Gath D, Mayou R Oxford Textbook of Psychiatry, second edition. Oxford: Oxford Universtiy Press, 1988
19. Tibaldi G, Munizza C, Bollini P Utilization of neuroleptic drugs in Italian mental health sevices:a survey in Piedmant. Psychiatric Services 1977;48:213-217
20. Tyrer P. Drug treatment of psychiatric patients in genereal practice. Br Med J 1978;2:1008-1010
21. Famuyiwa OO. Intra-city differences in psychatrapic drug use: a Nigerian scene. J R Soc Health 1996;116:299-303
22. Klett CJ, Caffey E Jr. Evaluating the long term need for antiparkinson drugs by chronic schizophrenics. Arch Gen Psychiatry 1972;26:374-379
23. James WS. Introducing quality assurance to a state hospital medical staff. Psychiatr Clin North Am 1990;13:25-34